obesity drug news today glp-1 september 29 2025 New oral drugs could offer more options for weight loss Obesity Week 2025 Medications
Description
The approval marks another milestone for the fast-growing class of weight-loss medicines, with Novo Nordisk indicating the Wegovy tablets are expected to reach the market within weeks
Over the years, researchers have followed this drug to see who it harms in certain organ systems and haven't seen any significant red flags in the heart or blood vessels [7]
Here are the details
Their clinic offering brings that decades-long behavioral science expertise into the GLP-1 er
